Mustang bio inc

Major-Pharmaceuticals

MBIO


2 Gansevoort Street
New York , NY 10014

Executive/
Director

Price

  • Last Close
  • $ 0.33
    $ -0.04 -11.44 %
    Apr 3, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 1,371,833
  • Market Cap Full
  • $ 8.2M
  • Shares Outstanding
  • 25M
    Mar 30, 2017
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - -8.8% 16% -5% -12.3% -39.8% -7.1% -
Q2 - - - -37.3% 8.9% 4% - -42.4% -11.4% -
Q3 - - 20.8% -13.4% -9.3% 8% -19% -19.8% - -
Q4 - - 7.5% -47.6% 9% 20.2% -37.4% -15.8% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 71.7% -18.9% -33.3% -11.4% - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%-75%27%1%-55%-77%-18%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - -0.24 -0.34 -0.28 -0.19 -3 -2.06
Q2 - - - -0.19 -0.29 -0.32 -0.16 -2.85 -2.00
Q3 - - 0.27 -0.28 -0.25 -0.23 -0.19 -2.7 -1.23
Q4 - - 0.22 -0.43 -0.41 -0.31 -3.3 -2.70 -
A 0 0 0.5 -1.1 -1.3 -1.14 -0.8 -0.8 -5.29

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.3 - - 0.2 -
Debt – Equity Ratio 0.6 - - 0.2 -
Interest Coverage -38 67 -19 - -
Equity multiplier 0.2 0.1 0.1 0.2 0.2